Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study.


Paz-Ares L. G., Dvorkin M., Chen Y., Reinmuth N., Hotta K., Trukhin D., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.38, no.15, 2020 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 38 Issue: 15
  • Publication Date: 2020
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Istanbul University Affiliated: Yes